JP2008523153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008523153A5 JP2008523153A5 JP2007546852A JP2007546852A JP2008523153A5 JP 2008523153 A5 JP2008523153 A5 JP 2008523153A5 JP 2007546852 A JP2007546852 A JP 2007546852A JP 2007546852 A JP2007546852 A JP 2007546852A JP 2008523153 A5 JP2008523153 A5 JP 2008523153A5
- Authority
- JP
- Japan
- Prior art keywords
- ginger
- green tea
- reducing
- disease
- symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims 4
- 241000234314 Zingiber Species 0.000 claims 4
- 235000009569 green tea Nutrition 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 235000008397 ginger Nutrition 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 229940098465 tincture Drugs 0.000 claims 2
- 241000196324 Embryophyta Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229940002508 ginger extract Drugs 0.000 claims 1
- 235000020708 ginger extract Nutrition 0.000 claims 1
- 229940094952 green tea extract Drugs 0.000 claims 1
- 235000020688 green tea extract Nutrition 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/012,764 US7166435B2 (en) | 2001-08-06 | 2004-12-14 | Compositions and methods for reducing the transmissivity of illnesses |
| PCT/US2005/045218 WO2006065889A2 (en) | 2004-12-14 | 2005-12-14 | Compositions and methods for reducing the transmissivity of illnesses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008523153A JP2008523153A (ja) | 2008-07-03 |
| JP2008523153A5 true JP2008523153A5 (enExample) | 2009-02-26 |
Family
ID=36588501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546852A Pending JP2008523153A (ja) | 2004-12-14 | 2005-12-14 | 疾病の伝染を減少させる組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7166435B2 (enExample) |
| EP (1) | EP1825007A4 (enExample) |
| JP (1) | JP2008523153A (enExample) |
| KR (1) | KR20070102487A (enExample) |
| CN (1) | CN101111608A (enExample) |
| AU (1) | AU2005317104A1 (enExample) |
| CA (1) | CA2590340A1 (enExample) |
| IL (1) | IL183840A0 (enExample) |
| MX (1) | MX2007007075A (enExample) |
| NZ (1) | NZ555778A (enExample) |
| WO (1) | WO2006065889A2 (enExample) |
| ZA (1) | ZA200704718B (enExample) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7166435B2 (en) * | 2001-08-06 | 2007-01-23 | The Quigley Corporation | Compositions and methods for reducing the transmissivity of illnesses |
| US20100286462A1 (en) * | 2002-12-19 | 2010-11-11 | Araba L.L.C. | Apparati and Method for Remediating Biologically Active Particles |
| KR20060113907A (ko) * | 2003-09-29 | 2006-11-03 | 에테나 헬스케어 인코포레이티드 | 높은 알코올 함량의 겔-유사 및 포옴 조성물 |
| DE102004062775A1 (de) | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alkoholischer Pumpschaum |
| CN103417388A (zh) | 2005-03-07 | 2013-12-04 | 戴博全球保健有限公司 | 含有有机硅表面活性剂的高醇含量发泡组合物 |
| US20060204466A1 (en) * | 2005-03-08 | 2006-09-14 | Ecolab Inc. | Hydroalcoholic antimicrobial composition with skin health benefits |
| US7507425B2 (en) * | 2005-09-27 | 2009-03-24 | The Quigley Corporation | Method for the treatment of cachexia |
| WO2007046966A2 (en) * | 2005-10-13 | 2007-04-26 | Milkhaus Laboratory, Inc | Methods for the treatment of influenza |
| WO2007056811A1 (en) * | 2005-11-16 | 2007-05-24 | Natbio Pty Ltd | Zingiber plant extract |
| US20070148101A1 (en) * | 2005-12-28 | 2007-06-28 | Marcia Snyder | Foamable alcoholic composition |
| GB0602325D0 (en) * | 2006-02-06 | 2006-03-15 | Remedy Res Ltd | Virucidal compositions and uses |
| CN101557815A (zh) * | 2006-12-14 | 2009-10-14 | 奎格利公司 | 用于治疗传染性支气管炎的组合物和方法 |
| AU2007333045A1 (en) * | 2006-12-14 | 2008-06-19 | The Quigley Corporation | Methods for treating and reducing the incidence of newcastle disease |
| KR101481040B1 (ko) * | 2008-03-31 | 2015-01-14 | 한국화학연구원 | [10]-진저다이온 또는 1-데하이드로-[10]-진저다이온을 포함하는 항 염증용 조성물 |
| US20090324734A1 (en) * | 2008-06-26 | 2009-12-31 | Daniel Dickey | Throat care composition |
| US7842725B2 (en) | 2008-07-24 | 2010-11-30 | Ecolab USA, Inc. | Foaming alcohol compositions with selected dimethicone surfactants |
| US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
| FR2937538B1 (fr) * | 2008-10-23 | 2010-12-31 | Muselier Corinne Treger | Produit antigrippal |
| AU2009319881C1 (en) * | 2008-11-26 | 2015-12-24 | Perio Sciences, Llc | Antioxidant compositions for soft oral tissue and methods of formulation and use thereof |
| WO2010062260A1 (en) * | 2008-11-29 | 2010-06-03 | The Thailand Research Fund | Virus and target cell interaction inhibition |
| US20100151056A1 (en) * | 2008-12-16 | 2010-06-17 | Hanan Polansky | Dietary supplements for decreasing the latent foreign dna load |
| US20100178364A1 (en) * | 2009-01-12 | 2010-07-15 | Hanan Polansky | Dietary supplements against latent foreign DNA |
| US8906414B1 (en) | 2009-04-27 | 2014-12-09 | University Of South Florida | Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG) |
| KR101186264B1 (ko) * | 2009-06-12 | 2012-09-27 | 한국생명공학연구원 | 산자나무 추출물 또는 이로부터 분리된 화합물을 포함하는 il-6으로 매개되는 질환 또는 라이노바이러스 감염성 질환의 예방 또는 치료용 조성물 |
| KR101077920B1 (ko) | 2009-07-08 | 2011-10-31 | 한국생명공학연구원 | 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물 |
| WO2011005043A2 (ko) * | 2009-07-08 | 2011-01-13 | 한국생명공학연구원 | 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물 |
| US20110052727A1 (en) * | 2009-08-31 | 2011-03-03 | Hanan Polansky | Anti Influenza Nutritional Supplements |
| KR101032066B1 (ko) * | 2009-10-08 | 2011-05-02 | 한국생명공학연구원 | 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물 |
| CN102665741B (zh) | 2009-10-22 | 2017-07-04 | 马雷辛斯制药有限公司 | 用于治疗感冒和流感的包含姜和一枝黄花的草本组合物 |
| BR112012015959A2 (pt) * | 2009-12-29 | 2019-09-24 | Hills Pet Nutrition Inc | composições incluindo gengibre para a melhora ou prevenção de condições inflamatórias |
| KR101282990B1 (ko) * | 2011-05-30 | 2013-07-04 | 건국대학교 산학협력단 | 항 인플루엔자 활성을 갖는 녹차 및 녹차부산물의 지용성 분획과 이로부터 분리된 글리세롤 당지질 화합물 |
| US9421180B2 (en) | 2011-09-30 | 2016-08-23 | Perio Sciences, Llc | Antioxidant compositions for treatment of inflammation or oxidative damage |
| ES2928162T3 (es) * | 2013-03-15 | 2022-11-15 | Eyepoint Pharmaceuticals Inc | Composiciones, formulaciones y métodos para tratar enfermedades oculares |
| US9439841B2 (en) | 2013-06-06 | 2016-09-13 | Ecolab Usa Inc. | Alcohol based sanitizer with improved dermal compatibility and feel |
| NL1040474C2 (en) * | 2013-10-31 | 2015-05-04 | Veramed B V | Nasal compositions stimulating ciliary activity. |
| EP3074028B1 (en) * | 2013-11-27 | 2022-04-06 | Research Foundation Of The City University Of New York | Activity enhancing curcumin compositions and methods of use |
| CN104013888A (zh) * | 2014-07-01 | 2014-09-03 | 刘德学 | 治疗痰热郁肺型阻塞性肺气肿的中药组合物及其制备方法 |
| JP6446552B2 (ja) * | 2014-08-28 | 2018-12-26 | カリウェイ バイオファーマシューティカルズ カンパニー リミテッド | 体重と体脂肪減少に用いられる組成物およびその医薬品と使用 |
| US10537548B2 (en) | 2014-08-28 | 2020-01-21 | Caliway Biopharmaceuticals Co., Ltd. | Composition and medical product for reducing body weight and body fat, and use of said product |
| KR101687337B1 (ko) * | 2015-06-02 | 2016-12-16 | (주)이엘티사이언스 | 가축 방역용 발판 소독약품 복합조성물 및 그 제조방법 |
| EP3103465A1 (en) * | 2015-06-10 | 2016-12-14 | Raman Mehta | Formulations for the treatment of mucosal lesions |
| CN105012831A (zh) * | 2015-08-05 | 2015-11-04 | 李强 | 一种用于治疗月经不调的中药组合物 |
| US12447166B2 (en) | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| AU2017224113B2 (en) | 2016-02-25 | 2022-04-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| ITUA20161822A1 (it) * | 2016-03-18 | 2017-09-18 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago |
| WO2018099570A1 (en) * | 2016-12-02 | 2018-06-07 | Symrise Ag | Cosmetic blends |
| US11229578B2 (en) | 2018-01-09 | 2022-01-25 | E2Bio Life Sciences, Llc | Method and device for the enhancement of topical treatments for oral mucositis and other oral conditions |
| EP3714889A1 (en) * | 2019-03-29 | 2020-09-30 | F. Hoffmann-La Roche AG | Baloxavir for the prevention of transmission of influenza virus |
| KR102224051B1 (ko) * | 2019-04-04 | 2021-03-09 | 한국 한의학 연구원 | 건강 추출물을 유효성분으로 포함하는 중화항체 생성율 증진용 조성물 |
| CN114845707A (zh) * | 2019-10-25 | 2022-08-02 | 韩国生命工学研究院 | 用于预防或治疗猪流行性腹泻病毒感染的包含含有基于类姜黄色素的化合物和甘草提取物或其级分的复合物的组合物 |
| CN111402968B (zh) * | 2020-04-01 | 2023-11-03 | 上海交通大学 | 基于分子模拟发现山柰酚在covid-19病毒中的新用途 |
| KR102456749B1 (ko) | 2020-04-28 | 2022-10-21 | 서울대학교산학협력단 | 울금 (Curcuma longa) 추출물 또는 이로부터 분리한 세스퀴테르페노이드계 화합물을 유효성분으로 포함하는 돼지 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물 |
| US20210393679A1 (en) | 2020-06-18 | 2021-12-23 | MELISA INSTITUTE, GENOMICS & PROTEOMICS RESEARCH SpA | FORMULATION, USE AND METHOD FOR BROAD-SPECTRUM PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS CAUSED BY SARS-CoV-2 AND OTHER EMERGING VIRUSES |
| CA3185062A1 (en) | 2020-07-06 | 2022-01-13 | Gang Pu | Foaming mixed alcohol/water compositions comprising a structured alkoxylated siloxane |
| WO2022010906A1 (en) | 2020-07-06 | 2022-01-13 | Ecolab Usa Inc. | Peg-modified castor oil based compositions for microemulsifying and removing multiple oily soils |
| CN116075583A (zh) | 2020-07-06 | 2023-05-05 | 埃科莱布美国股份有限公司 | 包含烷基硅氧烷和水溶助剂/增溶剂的组合的发泡混合醇/水组合物 |
| WO2022036316A1 (en) * | 2020-08-14 | 2022-02-17 | North Carolina State University | Methods to use flavonoids for inhibition of sars-cov-2 and treatment of covid-19 |
| WO2022046668A1 (en) * | 2020-08-22 | 2022-03-03 | Luc Montagnier | Compositions and methods for reducing the transmissivity of illnesses |
| CN113975223A (zh) * | 2021-08-06 | 2022-01-28 | 华中科技大学 | 一种鼻腔清洗液 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2850151B2 (ja) | 1990-02-02 | 1999-01-27 | 日研フード本社株式会社 | 抗酸化ミネラル飲料及びその製造法 |
| US5120538A (en) * | 1990-02-05 | 1992-06-09 | Pt Darya-Varia Laboratoria | Combinations of compounds isolated from curcuma spp as anti-inflammatory agents |
| SE468893B (sv) | 1991-09-04 | 1993-04-05 | Tetra Alfa Holdings | Oeppningsanordning foer foerpackningsbehaallare |
| CN1060012A (zh) | 1991-09-20 | 1992-04-08 | 沈阳市铁西区科发医药饮料技术服务部 | 一种口香糖的制作方法 |
| US5248504A (en) * | 1992-03-02 | 1993-09-28 | Friedman William H | Method of treatment for nasal and sinus dysfunction |
| CN1072823A (zh) | 1992-06-13 | 1993-06-09 | 文士开 | 果酶茶的配制方法 |
| US6063381A (en) * | 1993-05-19 | 2000-05-16 | Staggs; Jeff J. | Therapeutic uses of pungent botanicals and their related compounds |
| US5401504B1 (en) * | 1993-12-28 | 1998-04-21 | Univ Mississippi Medical Cente | Use of tumeric in wound healing |
| CN1116068A (zh) | 1994-01-25 | 1996-02-07 | 刘俊松 | 天然乳化果茶主剂的制备方法 |
| KR970701543A (ko) * | 1994-03-18 | 1997-04-12 | 가자마 하치자에몬 | 감염증 치료약 |
| US5494668A (en) * | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
| US5707630A (en) * | 1996-01-04 | 1998-01-13 | Sabina International, Ltd. | Herbal compound for relief of PMS through menopausal symptoms |
| US5861415A (en) * | 1996-07-12 | 1999-01-19 | Sami Chemicals & Extracts, Ltd. | Bioprotectant composition, method of use and extraction process of curcuminoids |
| JPH11155538A (ja) * | 1997-11-27 | 1999-06-15 | Uenoya Bikouen:Kk | 生姜湯の製造方法 |
| JP2000157209A (ja) | 1998-11-27 | 2000-06-13 | Kagetoshi Kawauchi | 振り掛け健康食品 |
| US6174542B1 (en) * | 1999-07-01 | 2001-01-16 | Pms Mood Food, Inc. | Dietary supplements and food products for treating symptoms of PMS |
| US6261607B1 (en) * | 1999-10-19 | 2001-07-17 | Thomas Newmark | Composition for promoting prostate health containing selenium and herbal extracts |
| US6264995B1 (en) | 1999-10-19 | 2001-07-24 | Thomas Newmark | Herbal composition for reducing inflammation and methods of using same |
| US6291533B1 (en) * | 1999-12-22 | 2001-09-18 | Vitamerica, Inc. | Dietary supplements for each specific blood type |
| US6841544B2 (en) * | 2000-02-23 | 2005-01-11 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
| US6274177B1 (en) * | 2000-08-26 | 2001-08-14 | National Science Council | Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract |
| US6391346B1 (en) * | 2001-04-05 | 2002-05-21 | Thomas Newmark | Anti-inflammatory, sleep-promoting herbal composition and method of use |
| US7396546B2 (en) * | 2001-08-06 | 2008-07-08 | The Quigley Corporation | Anti-microbial compositions and methods of using same |
| US6592896B2 (en) | 2001-08-06 | 2003-07-15 | The Quigley Corporation | Medicinal composition and method of using it |
| US6596313B2 (en) | 2001-08-06 | 2003-07-22 | The Quigley Corporation | Nutritional supplement and methods of using it |
| US7166435B2 (en) * | 2001-08-06 | 2007-01-23 | The Quigley Corporation | Compositions and methods for reducing the transmissivity of illnesses |
| CN1674875A (zh) * | 2002-08-06 | 2005-09-28 | 奎格利公司 | 抗微生物组合物及其应用方法 |
-
2004
- 2004-12-14 US US11/012,764 patent/US7166435B2/en not_active Expired - Fee Related
-
2005
- 2005-12-14 NZ NZ555778A patent/NZ555778A/en unknown
- 2005-12-14 AU AU2005317104A patent/AU2005317104A1/en not_active Abandoned
- 2005-12-14 KR KR1020077013374A patent/KR20070102487A/ko not_active Withdrawn
- 2005-12-14 CN CNA2005800476619A patent/CN101111608A/zh active Pending
- 2005-12-14 JP JP2007546852A patent/JP2008523153A/ja active Pending
- 2005-12-14 WO PCT/US2005/045218 patent/WO2006065889A2/en not_active Ceased
- 2005-12-14 EP EP05854017A patent/EP1825007A4/en not_active Withdrawn
- 2005-12-14 CA CA002590340A patent/CA2590340A1/en not_active Abandoned
- 2005-12-14 MX MX2007007075A patent/MX2007007075A/es unknown
-
2006
- 2006-10-27 US US11/553,656 patent/US7405046B2/en not_active Expired - Lifetime
-
2007
- 2007-06-11 IL IL183840A patent/IL183840A0/en unknown
- 2007-06-12 ZA ZA200704718A patent/ZA200704718B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008523153A5 (enExample) | ||
| RU2350327C2 (ru) | Составы, вызывающие потерю веса | |
| Qu et al. | Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats | |
| RU2470016C2 (ru) | Производное бипиразола | |
| JP2010535814A5 (enExample) | ||
| WO2007015824A3 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| JP2007302683A5 (enExample) | ||
| MY169275A (en) | Method of immunization against the four serotypes of dengue | |
| JP2012530723A5 (enExample) | ||
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| CL2007001917A1 (es) | Compuestos derivados de azaindol espirociclicos; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del dolor, condiciones de panico, depresion, mal de alzheimer, migrana, entre otras. | |
| JP2010540547A5 (enExample) | ||
| JP2013537891A5 (enExample) | ||
| CL2009001899A1 (es) | Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01). | |
| JP2019530713A5 (enExample) | ||
| FR2878161B1 (fr) | Forme medicamenteuse orale, solide et concue pour eviter le mesusage | |
| DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
| RU2017127509A (ru) | Композиции и способы для улучшенного мышечного метаболизма | |
| JP2006511538A5 (enExample) | ||
| JP2009515987A5 (enExample) | ||
| WO2007048027A3 (en) | Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent | |
| WO2007056721A3 (en) | Treatment of chronic kidney disease (ckd) subjects using lanthanum compounds | |
| UY29445A1 (es) | Composiciones para la transmisión transmucosa oral de la metformina | |
| EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия |